EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases

Shoji Kudoh

The American Journal of Medicine Supplements · 2004

DOI: 10.1016/j.amjmed.2004.07.024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The American Journal of Medicine Supplements, 2004. Verfasst von Shoji Kudoh. Beteiligte Einrichtung: Nippon Medical School, Tokyo, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In addition to having antibacterial effects, macrolides modulate inflammatory responses. Their effectiveness in treating chronic inflammatory airway disease is well documented in patients with diffuse panbronchiolitis (DPB), a chronic condition characterized by inflammation of the airways that, if left untreated, progressively leads to respiratory failure and death. Long-term treatment with certain macrolides has dramatically improved the survival of patients with DPB. The mechanisms of action for the anti-inflammatory properties of macrolides are still being studied. The effects of macrolides on inflammation include decreasing chemotaxis of neutrophils to the respiratory tract and inhibiting the expression of adhesion molecules, with decreased infiltration of neutrophils into the respiratory epithelium. Macrolides also inhibit expression of transcription factors and formation of proinflammatory cytokines, and directly and indirectly block mucus secretion. Even with long-term use, macrolides are safe and well tolerated. The effectiveness of macrolides for treating DPB has led to interest in their use in treating other chronic inflammatory airway diseases. As discussed in this article, because of the similarities between the clinical presentation of cystic fibrosis and chronic bronchitis and DPB, the effects of macrolides in patients with these diseases are currently being studied with particular interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAnti-Inflammatory AgentsBronchiolitisBronchitisChronic DiseaseCystic FibrosisHumansInflammationMacrolidesTreatment Outcome

Substanzen

Anti-Bacterial AgentsAnti-Inflammatory AgentsMacrolides

Autor:innen und Institutionen

  • Nippon Medical School, Tokyo, Japan.

Zitieren

APA

Kudoh, S. (2004). Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. The American Journal of Medicine Supplements. https://doi.org/10.1016/j.amjmed.2004.07.024

Vancouver

Kudoh S. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. The American Journal of Medicine Supplements. 2004. doi:10.1016/j.amjmed.2004.07.024

BibTeX
@article{Kudoh2004,
  author = {Kudoh, Shoji},
  title = {Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases},
  journal = {The American Journal of Medicine Supplements},
  year = {2004},
  doi = {10.1016/j.amjmed.2004.07.024}
}
Kostenlos starten →